FMS樣酪氨酸激酶3(Flt3)多克隆抗體(生物素標記)
Biotin-Linked Polyclonal Antibody to FMS Like Tyrosine Kinase 3 (Flt3)
CD135; STK1; FLK2; Fms-Related Tyrosine Kinase 3; Stem Cell Tyrosine Kinase 1; FL Cytokine Receptor; Fetal Liver Kinase-2
- 編號LAA039Mu71
- 物種Mus musculus (Mouse，小鼠)相同的名稱，不同的物種。
- 來源抗體標記
- Ig類型IgG
- 純化方式抗原特異性親和純化
- 標記物生物素
- 原抗體PAA039Mu01-FMS樣酪氨酸激酶3(Flt3)多克隆抗體
- 緩沖液成份0.01M 磷酸鹽緩沖液（pH7.4，containing 0.05% Proclin-300，50% glycerol）
- 性狀液體
- 濃度500μg/mL
- 且適物種-
- 應用WB; IHC; ICC.
如果抗體需用于流式細胞術(shù)，請參見流式抗體。 - 下載英文說明書 中文說明書
- 規(guī)格20μl100μl200μl1ml10ml
- 價格¥ 641¥ 1495¥ 2136¥ 5340¥ 21360
- 欲了解實際交易價格和更多情況，請與當?shù)亟?jīng)銷商聯(lián)系!
產(chǎn)品包裝(模擬)
產(chǎn)品包裝(模擬)
通過ISO 9001、ISO 13485質(zhì)量體系認證
特異性
該抗體是針對Flt3的兔多克隆抗體。在免疫組織化學染色和免疫印跡實驗中能識別Flt3。
用法
[ APPLICATIONS ]
Western blotting: 0.5-2ug/ml
Immunocytochemistry in formalin fixed cells: 5-20ug/ml
Immunohistochemistry in formalin fixed frozen section: 5-20ug/ml
Immunohistochemistry in paraffin section: 5-20ug/ml
Enzyme-linked Immunosorbent Assay: 0.05-2ug/ml
Optimal working dilutions must be determined by end user.
儲存
經(jīng)常使用則4°C保存。-20°C保存不超過兩年。避免反復凍融。
穩(wěn)定性
熱穩(wěn)定性以損失率顯示。損失率是由加速降解試驗決定，具體方法如下：在37°C孵育48小時，沒有顯著的降解或者沉淀產(chǎn)生。保質(zhì)期內(nèi)，在適當?shù)臈l件下存儲，損失率低于5%。
贈品
增值服務
相關產(chǎn)品
| 編號 | 適用物種：Mus musculus (Mouse，小鼠) | 應用(僅供研究使用，不用于臨床診斷！) |
| RPA039Mu01 | FMS樣酪氨酸激酶3(Flt3)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| PAA039Mu01 | FMS樣酪氨酸激酶3(Flt3)多克隆抗體 | WB |
| LAA039Mu71 | FMS樣酪氨酸激酶3(Flt3)多克隆抗體(生物素標記) | WB; IHC; ICC. |
參考文獻
| 雜志 | 參考文獻 |
| Frontiers in physiology | Alpha-1 Antitrypsin Prevents the Development of Preeclampsia Through Suppression of Oxidative Stress[pubmed:27303303] |
| PLoS One | Evaluation of surfactant proteins A, B, C, and D in articular cartilage, synovial membrane and synovial fluid of healthy as well as patients with osteoarthritis and?…[Pubmed: 30235245] |
| Bioscience Reports | N-Acetylcysteine inhalation improves pulmonary function in patients received Liver Transplantation.[Doi: 10.1042/BSR20180858] |
| Molecular Neurobiology | Elevated levels of multifunctional surfactant proteins in cerebrospinal fluid are associated with signs of increased cerebrospinal fluid flow in cranial magnetic?…[Doi: 10.1007/s12035-017-0835-5] |
| Cancers | Rationale for a Combination Therapy Consisting of MCL1-and MEK-Inhibitors in Acute Myeloid Leukemia[Pubmed: 31718075] |